Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN(®)) and Follow-Up Considerations/Recommendations

Current management of diabetic macular edema (DME) predominantly involves treatment with short-acting intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) and/or corticosteroids; however, short-acting therapies (lasting between 1 and 6 months) require frequent injections...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Adán, Alfredo, Cabrera, Francisco, Figueroa, Marta S, Cervera, Enrique, Ascaso, Francisco J, Udaondo, Patricia, Abraldes, Maximino, Reyes, Miguel Ángel, Pazos, Marta, Pessoa, Bernardete, Armadá, Félix
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398681/
https://ncbi.nlm.nih.gov/pubmed/32801618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S252359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados